Rivista sulle Malattie del Cuore e dei Vasi

Minerva Cardioangiologica 2016 Nov 23

Current aspects of pulmonary arterial hypertension and therapeutics

Xianchi LI, Yuanyuang LIU, Peiying ZHANG

Xuzhou Central Hospital, Xuzhou, Jiangsu Province, China

The pulmonary arterial hypertension (PAH) patients have high raet of morlatility due to right ventricle (or ventricular) (RV) failures. A lot of research work is being carried out in the area, however no treatments is available that could mange above rise in morality rates in PAH patients. β1-adrenoceptor blockers (β-blockers, BB) reduced mortality in left heart failure but they not much explored much at clinical level. Recent studies suggest β- blockers might be beneficial in PAH however the mechanisms remain unknown. The present review article would put light on all these aspeces of PAH along with latest avenues for the management of PAH.